These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 26857529
21. WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of Salmonella Typhimurium. Koide K, Kongsoi S, Nakajima C, Suzuki Y. Biosci Biotechnol Biochem; 2019 Dec; 83(12):2249-2256. PubMed ID: 31382821 [Abstract] [Full Text] [Related]
23. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. Okumura R, Hirata T, Onodera Y, Hoshino K, Otani T, Yamamoto T. J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884 [Abstract] [Full Text] [Related]
24. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Kitamura A, Hoshino K, Kimura Y, Hayakawa I, Sato K. Antimicrob Agents Chemother; 1995 Jul; 39(7):1467-71. PubMed ID: 7492087 [Abstract] [Full Text] [Related]
25. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase. Bhagwat SS, Mundkur LA, Gupte SV, Patel MV, Khorakiwala HF. Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059 [Abstract] [Full Text] [Related]
26. A fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuni. Han J, Wang Y, Sahin O, Shen Z, Guo B, Shen J, Zhang Q. Front Cell Infect Microbiol; 2012 Nov; 2():21. PubMed ID: 22919613 [Abstract] [Full Text] [Related]
27. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli. Qiu H, Gong J, Butaye P, Lu G, Huang K, Zhu G, Zhang J, Hathcock T, Cheng D, Wang C. FEMS Microbiol Lett; 2018 Jul 01; 365(13):. PubMed ID: 29767711 [Abstract] [Full Text] [Related]
28. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR. Said MM, El-Mohamady H, El-Beih FM, Rockabrand DM, Ismail TF, Monteville MR, Ahmed SF, Klena JD, Salama MS. J Infect Dev Ctries; 2010 Oct 04; 4(9):546-54. PubMed ID: 21045366 [Abstract] [Full Text] [Related]
29. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Microb Drug Resist; 2001 Oct 04; 7(3):257-61. PubMed ID: 11759087 [Abstract] [Full Text] [Related]
30. Amino Acid Substitution Ser83Ile in GyrA of DNA Gyrases Confers High-Level Quinolone Resistance to Nontyphoidal Salmonella Without Loss of Supercoiling Activity. Koide K, San LL, Pachanon R, Park JH, Ouchi Y, Kongsoi S, Utrarachkij F, Nakajima C, Suzuki Y. Microb Drug Resist; 2021 Oct 04; 27(10):1397-1404. PubMed ID: 33877914 [Abstract] [Full Text] [Related]
31. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida. Caspar Y, Siebert C, Sutera V, Villers C, Aubry A, Mayer C, Maurin M, Renesto P. Antimicrob Agents Chemother; 2017 Apr 04; 61(4):. PubMed ID: 28167561 [Abstract] [Full Text] [Related]
32. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis. Mehla K, Ramana J. OMICS; 2016 Nov 04; 20(11):635-644. PubMed ID: 27753544 [Abstract] [Full Text] [Related]
33. Bypassing fluoroquinolone resistance with quinazolinediones: studies of drug-gyrase-DNA complexes having implications for drug design. Drlica K, Mustaev A, Towle TR, Luan G, Kerns RJ, Berger JM. ACS Chem Biol; 2014 Dec 19; 9(12):2895-904. PubMed ID: 25310082 [Abstract] [Full Text] [Related]
34. Identification of the main quinolone resistance determinant in Campylobacter jejuni and Campylobacter coli by MAMA-DEG PCR. Hormeño L, Palomo G, Ugarte-Ruiz M, Porrero MC, Borge C, Vadillo S, Píriz S, Domínguez L, Campos MJ, Quesada A. Diagn Microbiol Infect Dis; 2016 Mar 19; 84(3):236-9. PubMed ID: 26658311 [Abstract] [Full Text] [Related]
35. Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones. Malik M, Mustaev A, Schwanz HA, Luan G, Shah N, Oppegard LM, de Souza EC, Hiasa H, Zhao X, Kerns RJ, Drlica K. Nucleic Acids Res; 2016 Apr 20; 44(7):3304-16. PubMed ID: 26984528 [Abstract] [Full Text] [Related]
36. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Madurga S, Sánchez-Céspedes J, Belda I, Vila J, Giralt E. Chembiochem; 2008 Sep 01; 9(13):2081-6. PubMed ID: 18677735 [Abstract] [Full Text] [Related]
37. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Malik M, Zhao X, Drlica K. Mol Microbiol; 2006 Aug 01; 61(3):810-25. PubMed ID: 16803589 [Abstract] [Full Text] [Related]
39. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing. Beckmann L, Müller M, Luber P, Schrader C, Bartelt E, Klein G. J Appl Microbiol; 2004 Oct 01; 96(5):1040-7. PubMed ID: 15078520 [Abstract] [Full Text] [Related]
40. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli. Hänninen ML, Hannula M. J Antimicrob Chemother; 2007 Dec 01; 60(6):1251-7. PubMed ID: 17911389 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]